
No. of Pages: 125 | Report Code: TIPRE00027167 | Category: Life Sciences
No. of Pages: 125 | Report Code: TIPRE00027167 | Category: Life Sciences
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Veterinary Vaccines Market – By Vaccine Type
1.3.2 MEA Veterinary Vaccines Market – By Technology
1.3.3 MEA Veterinary Vaccines Market – By Country
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion
5.1 Market Drivers
5.1.1 Surging Incidences of Zoonotic Diseases
5.1.2 Escalating Prevalence of Foodborne Diseases and Infections
5.2 Market Restraints
5.2.1 Strict Government Rules Related to Usage of Veterinary Vaccines
5.3 Market Opportunities
5.3.1 Market Expansion in Untapped Economies
5.4 Future Trends
5.4.1 Awareness of Diagnosis and Treatment of Variety of Infectious Diseases
5.5 Impact Analysis
6.1 MEA Veterinary Vaccines Market Revenue Forecast and Analysis
7.1 Overview
7.2 MEA Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)
7.3 Livestock Vaccines
7.3.1 Overview
7.3.2 Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.3.3 Bovine Vaccines
7.3.3.1 Overview
7.3.3.2 Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.3.4 Small Ruminant Vaccines
7.3.4.1 Overview
7.3.4.2 Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Companion Vaccines
7.4.1 Overview
7.4.2 Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.3 Feline Vaccines
7.4.3.1 Overview
7.4.3.2 Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.4 Canine Vaccines
7.4.4.1 Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.5 Other Companion Animal Vaccines
7.4.5.1 Overview
7.4.5.2 Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Others:
7.5.1 Overview
7.5.2 Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.1 Overview
8.2 MEA Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)
8.3 Live Attenuated Vaccines
8.3.1 Overview
8.3.2 Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.4 Inactivated Vaccines
8.4.1 Overview
8.4.2 Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.5 Toxoid Vaccines
8.5.1 Overview
8.5.2 Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.6 Recombinant Vaccines
8.6.1 Overview
8.6.2 Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
9.1 MEA: Veterinary Vaccines Market
9.1.1 Overview
9.1.2 MEA: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
9.1.2.1 Saudi Arabia: Veterinary Vaccines Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.1.1 Saudi Arabia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.1.2 Saudi Arabia Veterinary Vaccines Market, by Vaccine Type– Revenue and Forecast to 2028 (USD Million)
9.1.2.1.2.1 Saudi Arabia Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
9.1.2.1.2.2 Saudi Arabia Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
9.1.2.1.3 Saudi Arabia: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.1.2.2 UAE: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.1 UAE: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.2 UAE Veterinary Vaccines Market, by Vaccine Type– Revenue and Forecast to 2028 (USD Million)
9.1.2.2.2.1 UAE Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
9.1.2.2.2.2 UAE Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
9.1.2.2.3 UAE: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.1.2.3 South Africa: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.1 South Africa: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.2 South Africa Veterinary Vaccines Market, by Vaccine Type– Revenue and Forecast to 2028 (USD Million)
9.1.2.3.2.1 South Africa Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
9.1.2.3.2.2 South Africa Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
9.1.2.3.3 South Africa: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.1.2.4 Rest of MEA: Veterinary Vaccines Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.4.1 Rest of MEA: Veterinary Vaccines Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.4.2 Rest of MEA Veterinary Vaccines Market, by Vaccines Type– Revenue and Forecast to 2028 (USD Million)
9.1.2.4.2.1 Rest of MEA Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
9.1.2.4.2.2 Rest of MEA Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
9.1.2.4.3 Rest of MEA: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
10.1 MEA: Impact Assessment of COVID-19 Pandemic
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12.1 Boehringer Ingelheim International GmbH
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Zoetis Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck & Co., Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Virbac
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BIOVAC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 NEOGEN Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Elanco
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 HIPRA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Ceva
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Hester Biosciences Limited
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13.1 About The Insight Partners
13.2 Glossary of Terms
Table 1. MEA Veterinary Vaccines Market – Revenue, and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia Veterinary Vaccines Market, by Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 6. UAE Veterinary Vaccines Market, by Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 9. UAE Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Veterinary Vaccines Market, by Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 13. South Africa Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of MEA Veterinary Vaccines Market, by Vaccines Type– Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of MEA Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of MEA Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of MEA Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 18. Organic Developments Done by Companies
Table 19. Inorganic Developments Done by Companies
Table 20. Glossary of Terms
Figure 1. MEA Veterinary Vaccines Market Segmentation
Figure 2. MEA Veterinary Vaccines Market, By Country
Figure 3. MEA Veterinary Vaccines Market Overview
Figure 4. Livestock Vaccines Segment Held the Largest Share of the Market in 2021
Figure 5. The UAE is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. MEA: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints Pertaining to MEA Veterinary Vaccines Market
Figure 9. MEA Veterinary Vaccines Market – Forecast and Analysis to 2028
Figure 10. MEA Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)
Figure 11. MEA Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. MEA Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. MEA Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. MEA Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. MEA Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. MEA Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. MEA Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. MEA Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. MEA Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)
Figure 20. MEA Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. MEA Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. MEA Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. MEA Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. MEA Others: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. MEA: Veterinary Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 26. MEA: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
Figure 27. Saudi Arabia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. UAE: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. South Africa: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Rest of MEA: Veterinary Vaccines Market - Revenue and Forecast to 2028 (USD Million)
Figure 31. Impact Of COVID-19 Pandemic in MEA Country Markets
If you have any queries about this report or would like further information, please contact us:
North America: +1 646 491 9876
Asia-Pacific: +91 20 6727 8686
Email: info@theinsightpartners.com
All Rights Reserved.
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, “The Insight Partners”.